# Ares Capital Corp: financial statements, quarterly

ARCC · Nasdaq · CIK 1287750 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arcc.md) · [Financials](/companies/arcc/financials.md) · [Filings](/companies/arcc/filings.md) · [Insiders](/companies/arcc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/arcc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [157 d](/filings/0001287750-26-000006.md) | [159](/filings/0001287750-25-000020.md) | [174](/filings/0001287750-25-000038.md) | [195](/filings/0001287750-25-000046.md) | [187 d](/filings/0001287750-26-000006.md) | [186](/filings/0001628280-26-027688.md) | [188](/filings/0001628280-26-050307.md) | [209](/filings/0001628280-26-067383.md) | [210 d](/filings/0001287750-26-000006.md) | [213](/filings/0001628280-26-027688.md) | [214](/filings/0001628280-26-050307.md) | [221](/filings/0001628280-26-067383.md) |
| Net income | $m | [413 d](/filings/0001287750-26-000006.md) | [449](/filings/0001287750-25-000020.md) | [322](/filings/0001287750-25-000038.md) | [394](/filings/0001287750-25-000046.md) | [357 d](/filings/0001287750-26-000006.md) | [241](/filings/0001628280-26-027688.md) | [361](/filings/0001628280-26-050307.md) | [404](/filings/0001628280-26-067383.md) | [293 d](/filings/0001287750-26-000006.md) | [92.0](/filings/0001628280-26-027688.md) | [171](/filings/0001628280-26-050307.md) | [319](/filings/0001628280-26-067383.md) |
| Diluted EPS | $ per share | not reported | [0.76](/filings/0001287750-25-000020.md) | [0.52](/filings/0001287750-25-000038.md) | [0.62](/filings/0001287750-25-000046.md) | not reported | [0.36](/filings/0001628280-26-027688.md) | [0.52](/filings/0001628280-26-050307.md) | [0.57](/filings/0001628280-26-067383.md) | not reported | [0.13](/filings/0001628280-26-027688.md) | [0.24](/filings/0001628280-26-050307.md) | [0.44](/filings/0001628280-26-067383.md) |
| Basic EPS | $ per share | not reported | [0.76](/filings/0001287750-25-000020.md) | [0.52](/filings/0001287750-25-000038.md) | [0.62](/filings/0001287750-25-000046.md) | not reported | [0.36](/filings/0001628280-26-027688.md) | [0.52](/filings/0001628280-26-050307.md) | [0.57](/filings/0001628280-26-067383.md) | not reported | [0.13](/filings/0001628280-26-027688.md) | [0.24](/filings/0001628280-26-050307.md) | [0.44](/filings/0001628280-26-067383.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001287750-25-000007.md) | [0.5](/filings/0001287750-24-000028.md) | [0.6](/filings/0001287750-24-000039.md) | [0.5](/filings/0001287750-24-000054.md) | [0.6](/filings/0001287750-26-000006.md) | [0.6](/filings/0001287750-25-000020.md) | [0.4](/filings/0001287750-25-000038.md) | [1.0](/filings/0001287750-25-000046.md) | [0.6](/filings/0001628280-26-067383.md) | [0.5](/filings/0001628280-26-027688.md) | [0.4](/filings/0001628280-26-050307.md) | [0.7](/filings/0001628280-26-067383.md) |
| Total assets | $bn | [23.8](/filings/0001287750-25-000007.md) | [24.3](/filings/0001287750-24-000028.md) | [26.1](/filings/0001287750-24-000039.md) | [27.1](/filings/0001287750-24-000054.md) | [28.3](/filings/0001287750-26-000006.md) | [28.3](/filings/0001287750-25-000020.md) | [29.1](/filings/0001287750-25-000038.md) | [30.8](/filings/0001287750-25-000046.md) | [31.2](/filings/0001628280-26-067383.md) | [30.7](/filings/0001628280-26-027688.md) | [30.5](/filings/0001628280-26-050307.md) | [30.6](/filings/0001628280-26-067383.md) |
| Total liabilities | $bn | [12.6](/filings/0001287750-25-000007.md) | [12.4](/filings/0001287750-24-000028.md) | [13.7](/filings/0001287750-24-000039.md) | [14.3](/filings/0001287750-24-000054.md) | [14.9](/filings/0001287750-26-000006.md) | [14.6](/filings/0001287750-25-000020.md) | [15.0](/filings/0001287750-25-000038.md) | [16.5](/filings/0001287750-25-000046.md) | [16.9](/filings/0001628280-26-067383.md) | [16.6](/filings/0001628280-26-027688.md) | [16.6](/filings/0001628280-26-050307.md) | [16.7](/filings/0001628280-26-067383.md) |
| Long-term debt | $bn | [11.9](/filings/0001287750-25-000007.md) | [11.7](/filings/0001287750-24-000028.md) | [13.0](/filings/0001287750-24-000039.md) | [13.5](/filings/0001287750-24-000054.md) | [13.7](/filings/0001287750-26-000006.md) | [13.9](/filings/0001287750-25-000020.md) | [14.1](/filings/0001287750-25-000038.md) | [15.6](/filings/0001287750-25-000046.md) | [16.0](/filings/0001628280-26-067383.md) | [15.8](/filings/0001628280-26-027688.md) | [15.8](/filings/0001628280-26-050307.md) | [15.1](/filings/0001628280-26-067383.md) |
| Shareholders' equity | $bn | [11.2](/filings/0001287750-26-000006.md) | [11.9](/filings/0001287750-25-000046.md) | [12.4](/filings/0001287750-25-000046.md) | [12.8](/filings/0001287750-25-000046.md) | [13.4](/filings/0001628280-26-067383.md) | [13.7](/filings/0001628280-26-067383.md) | [14.0](/filings/0001628280-26-067383.md) | [14.3](/filings/0001628280-26-067383.md) | [14.3](/filings/0001628280-26-067383.md) | [14.1](/filings/0001628280-26-067383.md) | [13.9](/filings/0001628280-26-067383.md) | [13.9](/filings/0001628280-26-067383.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(359) d](/filings/0001287750-26-000006.md) | [(21.0)](/filings/0001287750-25-000020.md) | [(1,318) d](/filings/0001287750-25-000038.md) | [(521) d](/filings/0001287750-25-000046.md) | [(268) d](/filings/0001287750-26-000006.md) | [(299)](/filings/0001628280-26-027688.md) | [(218) d](/filings/0001628280-26-050307.md) | [(773) d](/filings/0001628280-26-067383.md) | [(427) d](/filings/0001287750-26-000006.md) | [184](/filings/0001628280-26-027688.md) | [336 d](/filings/0001628280-26-050307.md) | [1,052 d](/filings/0001628280-26-067383.md) |
| Dividends paid | $m | [263 d](/filings/0001287750-26-000006.md) | [270](/filings/0001287750-25-000020.md) | [279 d](/filings/0001287750-25-000038.md) | [287 d](/filings/0001287750-25-000046.md) | [303 d](/filings/0001287750-26-000006.md) | [308](/filings/0001628280-26-027688.md) | [317 d](/filings/0001628280-26-050307.md) | [320 d](/filings/0001628280-26-067383.md) | [319 d](/filings/0001287750-26-000006.md) | [345](/filings/0001628280-26-027688.md) | [345 d](/filings/0001628280-26-050307.md) | [346 d](/filings/0001628280-26-067383.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [555](/filings/0001287750-24-000028.md) | [567](/filings/0001287750-24-000039.md) | [582](/filings/0001287750-24-000054.md) | [591](/filings/0001287750-25-000020.md) | [616](/filings/0001287750-25-000038.md) | [635](/filings/0001287750-25-000046.md) | [676](/filings/0001628280-26-027688.md) | [695](/filings/0001628280-26-050307.md) | [709](/filings/0001628280-26-067383.md) | [718](/filings/0001628280-26-027688.md) | [718](/filings/0001628280-26-050307.md) | [720](/filings/0001628280-26-067383.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 722,194,973 at 2026-10-22, from the cover of the [10-Q filed 2026-10-27](/filings/0001628280-26-067383.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 06:27 ET. No prices; not investment advice.